Battling Lung Cancer With Combination Drug Therapy
Combination drug therapy may be needed to combat non-small cell lung cancer (NSCLC), according to a study by the Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI). The study, STAT3 is Activated by JAK2 Independent of Key Oncogenic Driver Mutation in Non-Small Cell Lung Carcinoma, was published online by the Public Library of Science (PLoS) ONE. The study found that in NSCLC - the most common form of lung cancer - that the STAT3 gene is activated in some NSCLC cell lines by the JAK2 protein... (Source: Health News from Medical News Today)
Patients With Anemia May Be At More Than Triple The Risk Of Dying After A Stroke
Being anemic could more than triple your risk of dying within a year after having a stroke, according to research presented at the American Stroke Association's International Stroke Conference 2012. Among stroke patients, severe anemia is a potent predictor of dying throughout the first year after a stroke, said Jason Sico, M.D., lead researcher and an assistant professor of neurology at Yale University School of Medicine in New Haven, Conn. Anemia is a common condition in which the body does not have enough healthy red blood cells... (Source: Health News from Medical News Today)
